North America
FDA’s Temporary Framework of AI/ML-based SaMD (part 2)
The last AI/ML blog described the basics, regulation, and premarket submission / modification. This blog will be discussing the risk categorization and TPLC (Total Product Life Cycle) of AI/ML-based SaMD. Artificial intelligence and machine learning is a new and...
